Dow Up 0.73% Nasdaq Up 0.60%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
0.64 Up 0.01(2.06%) Mar 28, 4:00PM EDT
|After Hours : 0.64 0.00 (0.00%) Mar 28, 4:38PM EDT
Prev Close:0.62
Open:0.60
Bid:0.58 x 1000
Ask:0.70 x 100
1y Target Est:8.00
Beta:2.15925
Earnings Date:May 8 - May 12 (Est.)
Day's Range:0.60 - 0.66
52wk Range:0.16 - 4.75
Volume:876,887
Avg Vol (3m):2,368,800
Market Cap:20.44M
P/E (ttm):N/A
EPS (ttm):-2.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEUp 2.06%20.44M
CELGDown 0.34%96.80B
VSTMDown 1.55%70.29M
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :-0.58
Quarterly EPS Est (Mar-17) :-0.22
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, develops hematology and oncology therapeutics that address unmet medical needs. The company develops GALE-401 (anagrelide controlled release), which completed Phase II clinical trial for the tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback